• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

癌细胞单层、球体和组织外植体中的实验性病毒进化。

Experimental virus evolution in cancer cell monolayers, spheroids, and tissue explants.

作者信息

Al-Zaher Ahmed, Domingo-Calap Pilar, Sanjuán Rafael

机构信息

Institute for Integrative Systems Biology (I2SysBio), Universitat de València-CSIC, C/ Catedrático Agustín Escardino 9, València 46980, Spain.

出版信息

Virus Evol. 2021 May 6;7(1):veab045. doi: 10.1093/ve/veab045. eCollection 2021 Jan.

DOI:10.1093/ve/veab045
PMID:34040797
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8134955/
Abstract

Viral laboratory evolution has been used for different applications, such as modeling viral emergence, drug-resistance prediction, and therapeutic virus optimization. However, these studies have been mainly performed in cell monolayers, a highly simplified environment, raising concerns about their applicability and relevance. To address this, we compared the evolution of a model virus in monolayers, spheroids, and tissue explants. We performed this analysis in the context of cancer virotherapy by performing serial transfers of an oncolytic vesicular stomatitis virus (VSV-Δ51) in 4T1 mouse mammary tumor cells. We found that VSV-Δ51 gained fitness in each of these three culture systems, and that adaptation to the more complex environments (spheroids or explants) correlated with increased fitness in monolayers. Most evolved lines improved their ability to suppress β-interferon secretion compared to the VSV-Δ51 founder, suggesting that the selective pressure exerted by antiviral innate immunity was important in the three systems. However, system-specific patterns were also found. First, viruses evolved in monolayers remained more oncoselective that those evolved in spheroids, since the latter showed concomitant adaptation to non-tumoral mouse cells. Second, deep sequencing indicated that viral populations evolved in monolayers or explants tended to be more genetically diverse than those evolved in spheroids. Finally, we found highly variable outcomes among independent evolutionary lines propagated in explants. We conclude that experimental evolution in monolayers tends to be more reproducible than in spheroids or explants, and better preserves oncoselectivity. Our results also suggest that monolayers capture at least some relevant selective pressures present in more complex systems.

摘要

病毒实验室进化已被用于不同的应用,如模拟病毒出现、预测耐药性以及优化治疗性病毒。然而,这些研究主要是在细胞单层中进行的,这是一个高度简化的环境,引发了对其适用性和相关性的担忧。为了解决这个问题,我们比较了一种模型病毒在单层、球体和组织外植体中的进化情况。我们通过在4T1小鼠乳腺肿瘤细胞中对溶瘤性水疱性口炎病毒(VSV-Δ51)进行连续传代,在癌症病毒治疗的背景下进行了这项分析。我们发现VSV-Δ51在这三种培养系统中的每一种中都获得了适应性,并且对更复杂环境(球体或外植体)的适应与在单层中的适应性增加相关。与VSV-Δ51原始毒株相比,大多数进化株提高了抑制β-干扰素分泌的能力,这表明抗病毒先天免疫施加的选择压力在这三种系统中都很重要。然而,也发现了系统特异性模式。首先,在单层中进化的病毒比在球体中进化的病毒更具肿瘤选择性,因为后者显示出对非肿瘤小鼠细胞的伴随适应性。其次,深度测序表明,在单层或外植体中进化的病毒群体往往比在球体中进化的病毒群体在基因上更加多样化。最后,我们发现在外植体中繁殖的独立进化株之间的结果差异很大。我们得出结论,在单层中的实验进化往往比在球体或外植体中更具可重复性,并且能更好地保持肿瘤选择性。我们的结果还表明,单层至少捕捉到了更复杂系统中存在的一些相关选择压力。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/127b/8134955/5bfbdf6cd82f/veab045f7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/127b/8134955/13e9ce27fbd7/veab045f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/127b/8134955/cbe4f0c3770e/veab045f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/127b/8134955/514d69371794/veab045f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/127b/8134955/bc17f3e6d992/veab045f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/127b/8134955/de625ecf983f/veab045f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/127b/8134955/2ccdb4240d16/veab045f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/127b/8134955/5bfbdf6cd82f/veab045f7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/127b/8134955/13e9ce27fbd7/veab045f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/127b/8134955/cbe4f0c3770e/veab045f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/127b/8134955/514d69371794/veab045f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/127b/8134955/bc17f3e6d992/veab045f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/127b/8134955/de625ecf983f/veab045f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/127b/8134955/2ccdb4240d16/veab045f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/127b/8134955/5bfbdf6cd82f/veab045f7.jpg

相似文献

1
Experimental virus evolution in cancer cell monolayers, spheroids, and tissue explants.癌细胞单层、球体和组织外植体中的实验性病毒进化。
Virus Evol. 2021 May 6;7(1):veab045. doi: 10.1093/ve/veab045. eCollection 2021 Jan.
2
Experimental Evolution Generates Novel Oncolytic Vesicular Stomatitis Viruses with Improved Replication in Virus-Resistant Pancreatic Cancer Cells.实验进化产生新型溶瘤单纯疱疹病毒,改善了对病毒耐药的胰腺癌细胞中的复制。
J Virol. 2020 Jan 17;94(3). doi: 10.1128/JVI.01643-19.
3
Reovirus FAST Protein Enhances Vesicular Stomatitis Virus Oncolytic Virotherapy in Primary and Metastatic Tumor Models.呼肠孤病毒FAST蛋白增强原发性和转移性肿瘤模型中水泡性口炎病毒的溶瘤病毒疗法。
Mol Ther Oncolytics. 2017 Aug 4;6:80-89. doi: 10.1016/j.omto.2017.08.001. eCollection 2017 Sep 15.
4
Radioiodide imaging and radiovirotherapy of multiple myeloma using VSV(Delta51)-NIS, an attenuated vesicular stomatitis virus encoding the sodium iodide symporter gene.使用VSV(Delta51)-NIS对多发性骨髓瘤进行放射性碘成像和放射病毒疗法,VSV(Delta51)-NIS是一种编码碘化钠同向转运体基因的减毒水疱性口炎病毒。
Blood. 2007 Oct 1;110(7):2342-50. doi: 10.1182/blood-2007-01-065573. Epub 2007 May 21.
5
Changes in Susceptibility to Oncolytic Vesicular Stomatitis Virus during Progression of Prostate Cancer.前列腺癌进展过程中对溶瘤性水疱性口炎病毒敏感性的变化
J Virol. 2015 May;89(10):5250-63. doi: 10.1128/JVI.00257-15. Epub 2015 Mar 4.
6
Interferon Beta and Interferon Alpha 2a Differentially Protect Head and Neck Cancer Cells from Vesicular Stomatitis Virus-Induced Oncolysis.β干扰素和α2a干扰素对头部和颈部癌细胞免受水疱性口炎病毒诱导的肿瘤溶解具有不同的保护作用。
J Virol. 2015 Aug;89(15):7944-54. doi: 10.1128/JVI.00757-15. Epub 2015 May 20.
7
Evolution in spatially mixed host environments increases divergence for evolved fitness and intrapopulation genetic diversity in RNA viruses.在空间混合的宿主环境中的进化增加了RNA病毒进化适应性和种群内遗传多样性的差异。
Virus Evol. 2016 Jan 20;2(1):vev022. doi: 10.1093/ve/vev022. eCollection 2016 Jan.
8
Generalized selection to overcome innate immunity selects for host breadth in an RNA virus.为克服先天免疫的广义选择决定了RNA病毒的宿主广度。
Evolution. 2016 Feb;70(2):270-81. doi: 10.1111/evo.12845. Epub 2016 Jan 20.
9
Characterization of the Impact of Oncolytic Vesicular Stomatitis Virus on the Trafficking, Phenotype, and Antigen Presentation Potential of Neutrophils and Their Ability to Acquire a Non-Structural Viral Protein.溶瘤性单纯疱疹病毒对中性粒细胞的迁移、表型和抗原呈递能力及其获取非结构病毒蛋白能力的影响特征。
Int J Mol Sci. 2020 Sep 1;21(17):6347. doi: 10.3390/ijms21176347.
10
Recent advances in vesicular stomatitis virus-based oncolytic virotherapy: a 5-year update.基于水疱性口炎病毒的溶瘤病毒疗法的最新进展:五年回顾
J Gen Virol. 2017 Dec;98(12):2895-2911. doi: 10.1099/jgv.0.000980.

引用本文的文献

1
Inactivated promotes a persistent antiviral immune status in porcine alveolar macrophages.灭活疫苗可促进猪肺泡巨噬细胞中持久的抗病毒免疫状态。
Front Immunol. 2025 Jun 3;16:1584092. doi: 10.3389/fimmu.2025.1584092. eCollection 2025.
2
Optimized Directed Virus Evolution to Accelerate the Generation of Oncolytic Coxsackievirus B3 Adapted to Resistant Colorectal Cancer Cells.优化定向病毒进化以加速溶瘤柯萨奇病毒B3的产生,该病毒适用于耐药结直肠癌细胞。
Viruses. 2024 Dec 20;16(12):1958. doi: 10.3390/v16121958.
3
Murine colon cancer derived cells exhibit heterogeneous resistance profiles against an oncolytic virus.

本文引用的文献

1
Recent advances of oncolytic virus in cancer therapy.溶瘤病毒在癌症治疗中的最新进展。
Hum Vaccin Immunother. 2020 Oct 2;16(10):2389-2402. doi: 10.1080/21645515.2020.1723363. Epub 2020 Feb 20.
2
Oncolytic Viruses and the Immune System: The Dynamic Duo.溶瘤病毒与免疫系统:活力二人组。
Mol Ther Methods Clin Dev. 2020 Jan 15;17:349-358. doi: 10.1016/j.omtm.2020.01.001. eCollection 2020 Jun 12.
3
The role of spatial structure in the evolution of viral innate immunity evasion: A diffusion-reaction cellular automaton model.
鼠源结肠癌衍生细胞对溶瘤病毒表现出异质性耐药谱。
Sci Rep. 2024 Nov 8;14(1):27209. doi: 10.1038/s41598-024-78313-6.
空间结构在病毒先天免疫逃避进化中的作用:一种扩散-反应细胞自动机模型。
PLoS Comput Biol. 2020 Feb 10;16(2):e1007656. doi: 10.1371/journal.pcbi.1007656. eCollection 2020 Feb.
4
Patient-derived explants (PDEs) as a powerful preclinical platform for anti-cancer drug and biomarker discovery.患者来源外植体(PDEs)作为一种强大的抗肿瘤药物和生物标志物发现的临床前研究平台。
Br J Cancer. 2020 Mar;122(6):735-744. doi: 10.1038/s41416-019-0672-6. Epub 2020 Jan 2.
5
Oncolytic Viruses for Cancer Therapy: Barriers and Recent Advances.用于癌症治疗的溶瘤病毒:障碍与最新进展
Mol Ther Oncolytics. 2019 Nov 2;15:234-247. doi: 10.1016/j.omto.2019.10.007. eCollection 2019 Dec 20.
6
Patient-derived explants, xenografts and organoids: 3-dimensional patient-relevant pre-clinical models in endometrial cancer.患者来源的外植体、异种移植物和类器官:子宫内膜癌的 3 维患者相关临床前模型。
Gynecol Oncol. 2020 Jan;156(1):251-259. doi: 10.1016/j.ygyno.2019.11.020. Epub 2019 Nov 22.
7
Experimental Evolution Generates Novel Oncolytic Vesicular Stomatitis Viruses with Improved Replication in Virus-Resistant Pancreatic Cancer Cells.实验进化产生新型溶瘤单纯疱疹病毒,改善了对病毒耐药的胰腺癌细胞中的复制。
J Virol. 2020 Jan 17;94(3). doi: 10.1128/JVI.01643-19.
8
Improving risk assessment of the emergence of novel influenza A viruses by incorporating environmental surveillance.通过整合环境监测来改进新型甲型流感病毒出现的风险评估。
Philos Trans R Soc Lond B Biol Sci. 2019 Sep 30;374(1782):20180346. doi: 10.1098/rstb.2018.0346. Epub 2019 Aug 12.
9
Directed evolution as a tool for the selection of oncolytic RNA viruses with desired phenotypes.定向进化作为一种用于筛选具有所需表型的溶瘤RNA病毒的工具。
Oncolytic Virother. 2019 Jul 12;8:9-26. doi: 10.2147/OV.S176523. eCollection 2019.
10
Updates to the antitumor mechanism of oncolytic virus.肿瘤溶瘤病毒抗肿瘤机制的研究进展。
Thorac Cancer. 2019 May;10(5):1031-1035. doi: 10.1111/1759-7714.13043. Epub 2019 Mar 22.